News and Trends 11 Nov 2022
PACT Pharma reports data from CRISPR cancer study
…of these T cells to mount a complete and effective attack on their cancer. PACT Pharma has developed technology platforms capable of creating engineered tumor-specific TCR-T cell therapies with the…